Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 3, 2008, Pages 369-376

  Strathdee, Steffanie A ^a   Lozada, Remedios ^b   Pollini, Robin A ^a   Brouwer, Kimberly C ^a   Mantsios, Andrea ^a   Abramovitz, Daniela A ^a   Rhodes, Tim ^c   Latkin, Carl A ^d   Loza, Oralia ^a   Alvelais, Jorge ^b   Magis Rodriguez, Carlos ^e   Patterson, Thomas L ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Patronato Pro COMUSIDA Comité Municipal de Prevención del SIDA   (Mexico)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Centro Nacional para la Prevencion Y Control del VIH/SIDA e ITS   (Mexico)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

HIV; Injection drug use; Mexico; Mobility; Policing; Sexually transmitted infections

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; MALE; MEXICO; MIGRATION; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL ASPECT; STRUCTURED INTERVIEW; SYPHILIS; BLOOD; MIDDLE AGED; STATISTICAL MODEL; SUBSTANCE ABUSE;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 42449102690     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318160d5ae     Document Type: Article

References (73)

1. Barnett T, Whiteside A. HIV/AIDS and development: case studies and a conceptual framework. Eur J Dev Res. 1999;11:200-234.
2. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13:85-94.
3. Friedman SR, Reid G. The need for dialectical models as shown in the response to the HIV/AIDS epidemic. Int J Sociol. 2002;22:177-200.
4. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38:67-78.
5. Rhodes T, Singer M, Bourgois P, et al. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026-1044.
6. Latkin CA, Knowlton AR. Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care. 2005;17(Suppl 1):S102-S113.
7. Bourgois P, Martinez A, Kral A, et al. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PLoS Med. 2006;3:e452.
8. Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36:2113-2136.
9. Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80:137-146.
10. Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction. 2006;101:1003-1013.
11. Tobin KE, Hua W, Costenbader EC, et al. The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend. 2007;87:63-68.
12. Latkin CA, Knowlton AR, Hoover D, et al. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am J Drug Alcohol Abuse. 1999;25:463-473.
13. Friedman SR, Kottiri BJ, Neaigus A, et al. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol. 2000;152:913-922.
14. Latkin CA, Mandell W, Vlahov D, et al. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol. 1996;24:341-364.
15. Page JB, Llanusa-Cestero R. Changes in the "get-off ": social process and intervention in risk locales. Subst Use Misuse. 2006;41:1017-1028.
16. Burris S, Blankenship KM, Donoghoe M, et al. Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82:125-156.
17. Cialdini RB, Kallgren CA, Reno RR. A focus theory of normative conduct: a theoretical refinement and reevaluation of the role of norms in human behavior. Advances in Experimental Social Psychology. 1991;24:201-234.
18. Celentano DD, Vlahov D, Cohn S, et al. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81:1291-1295.
19. Reyes JC, Robles RR, Colon HM, et al. Risk factors for shooting gallery use among drug injectors in Puerto Rico. P R Health Sci J. 1996;15:227-231.
20. Magis-Rodriguez C, Brouwer KC, Morales S, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs. 2005;37:333-339.
21. Rhodes T, Kimber J, Small W, et al. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction. 2006;101:1384-1393.
22. Dolan K, Kite B, Black E, et al. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7:32-41.
23. Rhodes T, Watts L, Davies S, et al. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Soc Sci Med. 2007;65:572-585.
24. Latkin C, Mandell W, Vlahov D, et al. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994;22:415-430.
25. Reyes JC, Robles RR, Colon HM, et al. Homelessness and HIV risk behaviors among drug injectors in Puerto Rico. J Urban Health. 2005;82:446-455.
26. German D, Davey MA, Latkin CA. Residential transience and HIV risk behaviors among injection drug users. AIDS Behav. 2007;11(6 Suppl):21-30.
27. Azim T, Chowdhury EI, Reza M, et al. Rising HIV prevalence among male injection drug users in Dhaka, Bangladesh. Subst Use Misuse. (In press).
28. Small W, Kerr T, Charette J, et al. Impacts of intensified police activity on injecting drug users: evidence from an ethnographic investigation. Int J Drug Policy. 2006;18:27-36.
29. Lloyd JJ, Ricketts EP, Strathdee SA, et al. Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am J Drug Alcohol Abuse. 2005;31:555-570.
30. Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57:39-54.
31. Cooper H, Moore L, Gruskin S, et al. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005;61:673-684.
32. Blankenship KM, Koester S. Criminal law, policing policy, and HIV risk in female street sex workers and injection drug users. J Law Med Ethics. 2002;30:548-559.
33. Strathdee SA, Fraga WD, Case P, et al. Vivo para consumirla y la consumo para vivir [I live to inject and inject to live]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005;82(Suppl 4):iv58-iv73.
34. Miller CL, Firestone M, Ramos R, et al. Injecting drug users' experiences of policing practices in two Mexican-US border cities: public health perspectives. Int J Drug Policy. 2007 Nov 8 [Epub ahead of press].
35. Bluthenthal RN, Kral AH, Erringer EA, et al. Drug paraphernalia laws and injection related infectious disease risk among drug injectors. J Drug Issues. 1999;29:1-16.
36. Bluthenthal RN, Lorvick J, Kral AH, et al. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. Int J Drug Policy. 1999;10:25-38.
37. Rhodes T, Judd A, Mikhailova L, et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: maximizing the protective effects of syringe distribution. J Acquir Immune Defic Syndr. 2004;35:293-300.
38. Pollini RA, Pollini RA, Brouwer KC, et al. Syringe possession arrests are associated with receptive syringe sharing in two U.S.-Mexico border cities. Addiction. (In press).
39. Wood E, Spittal PM, Small W, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ. 2004;170:1551-1556.
40. Davis CS, Burris S, Kraut-Becher J, et al. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health. 2005;95:233-236.
41. Friedman SR, Cooper HL, Tempalski B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006;20:93-99.
42. Hawkes SJ, Hart GJ. Travel, migration and HIV. AIDS Care. 1993;5:207-214.
43. Mayer JD. Geography, ecology and emerging infectious diseases. Soc Sci Med. 2000;50:937-952.
44. McMichael AJ. Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2004;359:1049-1058.
45. Soskolne V, Shtarkshall RA. Migration and HIV prevention programmes: linking structural factors, culture, and individual behaviour - an Israeli experience. Soc Sci Med. 2002;55:1297-1307.
46. Deren S, Kang SY, Colon HM, et al. Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. Am J Public Health. 2003;93:812-816.
47. Lagarde E, Schim van der Loeff M, Enel C, et al. Mobility and the spread of human immunodeficiency virus into rural areas of West Africa. Int J Epidemiol. 2003;32:744-752.
48. Organista KC, Carrillo H, Ayala G. HIV prevention with Mexican migrants: review, critique, and recommendations. J Acquir Immune Defic Syndr. 2004;37(Suppl 4):S227-S239.
49. Parrado EA, Flippen CA, McQuiston C. Use of commercial sex workers among Hispanic migrants in North Carolina: implications for the spread of HIV. Perspect Sex Reprod Health. 2004;36:150-156.
50. Deren S, Kang SY, Rapkin B, et al. The utility of the PRECEDE model in predicting HIV risk behaviors among Puerto Rican injection drug users. AIDS Behav. 2003;7:405-412.
51. Drucker E. Epidemic in the war zone: AIDS and community survival in New York City. Int J Health Serv. 1990;20:601-615.
52. Paschane DM, Fisher DG. Etiology of limited transmission diseases among drug users: does recent migration magnify the risk of sharing injection equipment? Soc Sci Med. 2000;50:1091-1097.
53. Freeman RC, Williams ML, Saunders LA. Drug use, AIDS knowledge, and HIV risk behaviors of Cuban-, Mexican-, and Puerto-Rican-born drug injectors who are recent entrants into the United States. Subst Use Misuse. 1999;34:1765-1793.
54. Kottiri BJ, Friedman SR, Neaigus A, et al. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002;30:95-104.
55. Brouwer KC, Lozada R, Cornelius WA, et al. Deportation along the U.S.-Mexico border: its relation to drug use patterns and accessing care. J Immigr Minor Health. (In press).
56. Instituto Nacional de Estadistica, Geografia e Informatica (INEGI). XII Censo General de Población y Vivienda 2000. 2000; México.
57. San Diego Association of Governments: San Diego-Baja California Land Ports of Entry Fact Sheet. Available at: http://www.sandag.org/uploads/ publicationid/publicationid_1184_5148.pdf. Accessed December 11, 2007.
58. Heckathorn D. Respondent driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174-199.
59. Magis-Rodriguez C, Gayet C, Negroni M, et al. Migration and AIDS in Mexico: an overview based on recent evidence. J Acquir Immune Defic Syndr. 2004;37(Suppl 4):S215-S226.
60. Ramos R, Miller CM, Firestone M, et al. Injecting drug users' experiences of policing parctices in two Mexican-US border cities. 17th International Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May 4, 2006 [plenary presentation].
61. Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88:188-196.
62. Farmer P, Connors M, Simmons J. Women, Poverty and AIDS: Sex, Drugs and Structural Violence: Monroe, ME: Common Courage Press; 1996.
63. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57:13-24.
64. Deng R, Li J, Sringernyuang L, et al. Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China. Soc Sci Med. 2007;64:1560-1571.
65. Peretti-Water P, Spire B, Obadia Y, et al. Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS ONE. 2007;2:e411.
66. Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166:894-899.
67. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
68. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
69. Cruz MF, Mantsios A, Ramos R, et al. A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behav. 2007;11:253-262.
70. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3-17.
71. Latkin CA, Forman V, Knowlton A, et al. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56:465-476.
72. Davey MA, Latkin CA, Hua W, et al. Individual and social network factors that predict entry to drug treatment. Am J Addict. 2007;16:38-45.
73. Wegbreit J, Bertozzi S, DeMaria LM, et al. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS. 2006;20:1217-1235.